Unternehmen
Transcend Therapeutics
Founded in 2021, Transcend Therapeutics is a late-clinical-stage neuroscience company developing rapid-acting treatments for neuropsychiatric diseases. Our lead asset TSND-201, a rapid-acting neuroplastogen, is the first and only product to demonstrate rapid, robust, and durable therapeutic effects in PTSD. TSND-201 was granted Breakthrough Therapy designation by the FDA based on Phase 2 results, and we have aligned on a Phase 3 program for TSND-201 in PTSD. Transcend is backed by leading life sciences investors and driven by a mission to create treatments for the millions of people for whom current psychiatric medicines have not worked.
Offene Stellen
5
jetzt online
Neu heute
0
letzte 24 Stunden
Weltweit remote
0
von überall
Abteilungen
1
stellen ein in
Manager, Clinical Operations (Patient Recruitment)
Transcend Therapeutics
● Neu
👁 Gesehen
✓ Beworben
vor 5 Mon.
Senior Associate, Clinical Operations
Transcend Therapeutics
● Neu
👁 Gesehen
✓ Beworben
vor 7 Mon.
Field Clinical Research Associate
Transcend Therapeutics
● Neu
👁 Gesehen
✓ Beworben
vor 7 Mon.
Associate Director, Clinical Operations
Transcend Therapeutics
● Neu
👁 Gesehen
✓ Beworben
vor 7 Mon.
Director, Clinical Development (MD required)
Transcend Therapeutics
● Neu
👁 Gesehen
✓ Beworben
vor 8 Mon.